7H

Neuca SAMUN Neuca Stock Report

Last reporting period 30 Jun, 2024

Updated 22 Oct, 2024

Last price

Market cap $B

0.938

Micro

Exchange

XMUN - Boerse Muenchen

7HD.MU Stock Analysis

7H

Neutral

Based on Eyestock quantitative analysis, 7HD.MU`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

55/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

0.8 %

Overvalued

Market cap $B

0.938

Dividend yield

2.96 %

Shares outstanding

4.431 B

NEUCA SA engages in the wholesale of pharmaceutical products. The company is headquartered in Torun, Woj. Kujawsko - Pomorskie and currently employs 3,852 full-time employees. The company went IPO on 2004-09-30. The firm is mainly involved in the distribution of drugs to pharmacies. The company also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.

View Section: Eyestock Rating